Efficient Gene Transfer into Primate Embryonic Stem Cells with Pluripotency Preserved

Strategic Insights -

Research published in the journal Gene Therapy has shown that embryonic cells can retain their pluripotent potential after being transfected with the Sendai virus. This breakthrough could have significant implications for gene therapy and stem cell research. By using the nonintegrating Sendai virus vector, scientists were able to introduce the green fluorescent protein gene into non-human primate cynomolgus embryonic stem cells, resulting in vigorous and stable expression of the gene for a year. The cells were also able to differentiate into various cell types, including neurons and blood cells, and form fluorescent teratomas when transplanted into immunodeficient mice.

Key Takeaways:

  • The Sendai virus vector was shown to be an efficient tool for gene transfer into primate embryonic stem cells, with the GFP gene being vigorously and stably expressed for a year.
  • The cells were able to retain their pluripotent potential after Sendai virus transfection, as they were able to differentiate into various cell types, including neurons and blood cells.
  • The use of an anti-RNA virus drug, ribavirin, was shown to reduce the expression levels of the GFP gene in a dose-dependent manner, suggesting that regulated gene expression can be achieved.
  • The study was conducted using non-human primate cynomolgus embryonic stem cells, which are a widely used model for human embryonic stem cells.
  • The results of this study have significant implications for gene therapy and stem cell research, as they provide a new tool for efficient gene transfer into embryonic stem cells.
  • The study authors, K. Sasaki and colleagues, published their findings in the journal Gene Therapy in 2005.

Statistics:

  • The GFP gene was expressed for a year after transfection with the Sendai virus vector.
  • The cells were able to differentiate into fluorescent neurones, embryoid bodies, and mature blood cells.
  • The dose-dependent reduction of GFP expression by ribavirin was demonstrated in a study involving cynomolgus embryonic stem cells.
  • The study used a nonintegrating Sendai virus vector, which reduces the risk of gene silencing and insertional mutagenesis.

Sources:

  • Gene Therapy, 2005;12(3):203-210
  • K. Sasaki et al. (2005) Efficient and stable Sendai virus-mediated gene transfer into primate embryonic stem cells with pluripotency preserved. Gene Therapy, 12(3), 203-210.
  • Nature Publishing Group, Macmillan Building, 4 Crinan St., London N1 9XW, England (publisher of Gene Therapy)
  • Health & Medicine Week editors (2005) Efficient Gene Transfer into Primate Embryonic Stem Cells with Pluripotency Preserved. Health & Medicine Week, via NewsRx.com.